PRAVEEN NARAHARI: Open Payments
NPI 1053549832 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 31 payments from 8 companies in 2025. Trend: 2023 $668 · 2024 $570 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $235 |
| Alkermes, Inc. | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Teva Pharmaceuticals USA, Inc. | 4 | $75 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| ABBVIE INC. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
Products named: COBENFY, ARISTADA, ABILIFY MAINTENA, UZEDY, SPRAVATO, CAPLYTA, LYBALVI, VRAYLAR.
Industry payments across FL — which companies pay providers there.
